We are live on
!
Find out more
FWM
Fairhaven Wealth Management Portfolio holdings
AUM
$320M
1-Year Est. Return
17.7%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+17.7%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$327M
AUM Growth
+$24.7M
(+8.2%)
Cap. Flow
+$3.67M
Cap. Flow
% of AUM
1.12%
Top 10 Holdings %
Top 10 Hldgs %
59.72%
Holding
129
New
9
Increased
50
Reduced
26
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$711K |
| 2 |
NVIDIA
NVDA
|
+$385K |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$292K |
| 4 |
TSMC
TSM
|
+$245K |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$241K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$218K |
| 2 |
Old Second Bancorp
OSBC
|
+$106K |
| 3 |
Tesla
TSLA
|
+$93.3K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$68.5K |
| 5 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$68.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.42% |
| 2 | Financials | 6.98% |
| 3 | Healthcare | 5.26% |
| 4 | Consumer Discretionary | 4.62% |
| 5 | Industrials | 3.76% |
Similar funds
WWP
AP
CIM
FIM
CSWM
BCA
GWM
ECG
Fairhaven Wealth Management's Q3 2024 Portfolio in Review
As of Q3 2024, Fairhaven Wealth Management held 129 positions worth $327M, up 8.2% from $302M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Fairhaven Wealth Management's Q3 2024 filing shows 9 new, 50 increased, 26 reduced and 1 closed positions. Its largest new stake was TSMC: 1,435 shares worth $249K. The largest sale was iShares Core S&P Small-Cap ETF, an estimated $218K.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- Fairhaven Wealth Management's largest Q3 2024 buy was TSMC: 1,435 shares worth $249K.
- Fairhaven Wealth Management added most to iShares Core MSCI EAFE ETF in Q3 2024, an estimated $711K increase.
- Fairhaven Wealth Management's biggest Q3 2024 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $218K.
- Fairhaven Wealth Management fully exited Revance Therapeutics, Inc. in Q3 2024, selling an estimated $38.2K.
- Fairhaven Wealth Management's ten largest holdings make up 60% of its $327M portfolio in Q3 2024.
- Fairhaven Wealth Management opened 9 new positions and closed 1 in Q3 2024.
- Fairhaven Wealth Management's portfolio value rose 8.2% quarter-over-quarter to $327M.
Based on Fairhaven Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.